Data / Form D filings / Sentonix, Inc.
Sentonix, Inc.: Form D filings
Sentonix, Inc., a pharmaceuticals company in Arlington, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on August 20, 2026, reports $12.7 million sold of a $21.2 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1167 MASSACHUSETTS AVE, Arlington, MA, 02476
- Phone
- (617) 388-6440
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2039609
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $21,203,719 | $12,704,719 | $8,499,000 | 17 | Aug 13, 2026 | sec.gov |
| May 12, 2025 | Amendment | $10,500,000 | $6,499,590 | $4,000,410 | 15 | Sep 23, 2024 | sec.gov |
| Oct 3, 2024 | New notice | $5,500,000 | $5,205,590 | $294,410 | 10 | Sep 23, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karl Schmidt | Executive Officer | COO |
| John Beaver | Executive Officer, Director | CEO |
| Kenan Turnacioglu | Executive Officer, Director | Secretary; Treasurer |
| Jack Hoppin | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sentonix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.